When Rebekah and Evan Lockard's daughter, Naomi, was diagnosed with a devastating ultra-rare genetic disease, they didn't know where to turn. Then they found Terry Pirovolakis, an IT professional who had made a gene therapy for his son with the same disease. But the process of getting Naomi treated has been an uphill battle, full of financial and logistical obstacles. The Lockard's story flips the question we've been asking all season on its head. Instead of wondering, "if we could do something, should we," we're now asking, "if we can do something that helps patients, should we do it at any cost?" And this question isn't for scientists or researchers, it's for the rest of us.
Podden och tillhörande omslagsbild på den här sidan tillhör
Science History Institute. Innehållet i podden är skapat av Science History Institute och inte av,
eller tillsammans med, Poddtoppen.